Medical journal
Appears in 1 story
Publisher of the TRIUMPH-1 results
People on the highest dose of Eli Lilly's experimental obesity drug lost an average of 30.3% of their body weight over 104 weeks — a result doctors previously saw almost only after bariatric surgery. The finding comes from TRIUMPH-1, a Phase 3 trial that randomized 2,339 adults with obesity or overweight to one of three doses of retatrutide or a placebo.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
